Financials

  • Market Capitalization 572.41 M
  • Employee 21
  • Founded 2012
  • CEO N/A
  • Website www.immixbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00HLCWH09
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2820
ALT
Altimmune, Inc. - Common Stock
2.99 USD-1.97%-2.92%+14.12%-30.30%581.48 M USD
2824
DRUG
Bright Minds Biosciences Inc. - common stock
75.93 USD-2.45%+11.88%+22.76%+192.49%579.79 M USD
2841
DNA
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
9.06 USD-0.66%-9.94%+10.22%+2.03%564.66 M USD
2893
ARVN
Arvinas, Inc. - Common Stock
8.10 USD-2.06%-7.85%+5.74%-12.90%522.62 M USD

Frequently asked questions about Immix Biopharma, Inc. - Common Stock

What is the Immix Biopharma, Inc. - Common Stock stock price today?

The current price of Immix Biopharma, Inc. - Common Stock (IMMX) is 10.52. Over the past 24 hours, the stock has changed by -5.31%. Follow the IMMX chart for real-time price dynamics.

What is the stock ticker of Immix Biopharma, Inc. - Common Stock?

Immix Biopharma, Inc. - Common Stock trades under the ticker IMMX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Immix Biopharma, Inc. - Common Stock stock going up?

IMMX has changed by -0.66% over the last week, +22.61% over the last month, and +262.76% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Immix Biopharma, Inc. - Common Stock net income for the last quarter?

Immix Biopharma, Inc. - Common Stock reported net income of -10.09 M for the last quarter. The previous quarter showed -10.69 M, which means net income changed by +5.62%.

How many employees does Immix Biopharma, Inc. - Common Stock have?

As of the latest available data, Immix Biopharma, Inc. - Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.

What is Immix Biopharma, Inc. - Common Stock EBITDA?

Immix Biopharma, Inc. - Common Stock EBITDA is -10.7 M, and its EBITDA margin is 45.51 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Immix Biopharma, Inc. - Common Stock stock?

You can buy Immix Biopharma, Inc. - Common Stock (IMMX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Immix Biopharma, Inc. - Common Stock stock?

Investing in Immix Biopharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMMX chart and related analysis on metatrader.com as part of your research.

News